Free Trial

Evolv Technologies (NASDAQ:EVLV) Shares Up 6.2% - Still a Buy?

Evolv Technologies logo with Computer and Technology background

Key Points

  • Evolv Technologies' stock price increased by 6.2% to $8.48, despite a trading volume decrease of 25% from its average session volume.
  • Analysts have a consensus rating of "Moderate Buy" for Evolv Technologies, with a target price averaging $8.88 and several upgrades from various equity research firms.
  • The company reported a quarterly earnings miss with an EPS of ($0.25), below the expected ($0.09), while generating $26.68 million in revenue against an estimate of $30.95 million.
  • Five stocks to consider instead of Evolv Technologies.

Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV - Get Free Report) shot up 6.2% during mid-day trading on Friday . The stock traded as high as $8.45 and last traded at $8.48. 1,857,601 shares traded hands during mid-day trading, a decline of 25% from the average session volume of 2,471,842 shares. The stock had previously closed at $7.98.

Analyst Upgrades and Downgrades

EVLV has been the subject of a number of research analyst reports. TD Cowen reissued a "buy" rating and set a $10.00 target price on shares of Evolv Technologies in a research report on Friday, August 15th. Northland Securities raised shares of Evolv Technologies from a "market perform" rating to an "outperform" rating and set a $7.50 target price for the company in a research report on Wednesday, May 21st. Lake Street Capital raised shares of Evolv Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $5.50 to $9.00 in a research report on Friday, August 15th. Northland Capmk raised shares of Evolv Technologies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 20th. Finally, Wall Street Zen raised shares of Evolv Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Evolv Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $8.88.

Check Out Our Latest Report on Evolv Technologies

Evolv Technologies Stock Up 8.6%

The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of -15.72 and a beta of 1.71. The stock's 50-day simple moving average is $7.14 and its 200 day simple moving average is $5.26.

Evolv Technologies (NASDAQ:EVLV - Get Free Report) last released its quarterly earnings results on Thursday, August 14th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by ($0.16). The firm had revenue of $26.68 million during the quarter, compared to analyst estimates of $30.95 million. Evolv Technologies had a negative net margin of 73.04% and a negative return on equity of 76.80%. Evolv Technologies has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Evolv Technologies Holdings, Inc. will post -0.27 earnings per share for the current year.

Hedge Funds Weigh In On Evolv Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EVLV. SCS Capital Management LLC acquired a new position in Evolv Technologies in the first quarter valued at about $15,061,000. Marshall Wace LLP lifted its position in shares of Evolv Technologies by 74.4% during the second quarter. Marshall Wace LLP now owns 3,899,155 shares of the company's stock worth $24,331,000 after purchasing an additional 1,662,797 shares in the last quarter. Gilder Gagnon Howe & Co. LLC acquired a new position in shares of Evolv Technologies during the second quarter worth approximately $7,041,000. Metavasi Capital LP acquired a new position in shares of Evolv Technologies during the second quarter worth approximately $4,874,000. Finally, Vanguard Group Inc. lifted its position in shares of Evolv Technologies by 5.3% during the first quarter. Vanguard Group Inc. now owns 9,402,716 shares of the company's stock worth $29,336,000 after purchasing an additional 477,124 shares in the last quarter. 66.65% of the stock is currently owned by institutional investors and hedge funds.

About Evolv Technologies

(Get Free Report)

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Evolv Technologies Right Now?

Before you consider Evolv Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evolv Technologies wasn't on the list.

While Evolv Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.